Increase Speed to Market: Utilizing Enhanced ATP Bioluminescence for Rapid Microbial Detection - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Increase Speed to Market: Utilizing Enhanced ATP Bioluminescence for Rapid Microbial Detection
A new adenosine triphosphate bioluminesence technology allows manufacturers to detect the presence of microbial contamination within 24–48 hours rather than the 3–5 days required by traditional methods.


Pharmaceutical Technology


Case Study: Decreasing Time for Mold Detection by 50%

Challenge: Many companies have microbial specifications for their products based on the USP guidelines, product history, and risk. When it comes to mold, this usually means being able to detect Aspergillus niger. This mold's slow growth is therefore typically the rate-determining step for product release. Additional requirements can make the process take even longer. One major pharmaceutical and personal-care products company manufactured products which required the detection of Penicillium expansum. This company was using standard bioluminescence (48-hour detection), however the restricted mold specification required an additional day of incubation—a time-to-release the company considered unacceptable.

Solution: Celsis worked with the company to modify their existing bioluminescence protocol to decrease their time to result without jeopardizing product quality. A study was performed on a water-based lotion for babies. Celsis examined how broth type, incubation temperature and conditions affect A. niger and P. expansum detection using both standard bioluminescence and AKuScreen reagents.


Table I: Results of Case Study 1, Decreasing Time for Mold Detection by 50%
Preliminary studies indicated that static incubation at room temperature optimizes the growth of P. expansum. The table below summarizes the study data. All samples were inoculated with <50 spores of P. expansum and incubated statically at room temperature (24–27° C). (See Table I)

This amplification allows for greater differentiation and a more sensitive measure of microbial contamination. Therefore, companies can more effectively screen products with elevated background of non-microbial ATP and products contaminated with adaptive, slow growing organisms. Also, the time to result is reduced to 18-24 hours compared to 24-48 hours with standard ATP bioluminescence and 3-5 days with traditional methods.

Case study: Detection of Slow-Growing Microorganisms

Challenge: A large consumer products company faced a contamination event with a fabric softener that had a pH of 4.0. Microorganisms can adapt to chemically hostile products such as these. Product-adapted microorganisms are usually fastidious and slow-growing, making it difficult to detect using traditional agar or standard bioluminescence methods. Following a prolonged incubation, the contaminating microorganism was isolated and identified as Acetobacter pasteurianus.

Solution: The manufacturer contacted Celsis for assistance in exploring the potential for testing its fabric softener product using ATP bioluminescence. The goal was to provide faster detection and faster correction of future contamination events. Although the Celsis bioluminescence technology is designed for the rapid detection of microorganisms, in order to detect low levels of contaminants an enrichment step is required to ensure that there is sufficient ATP present for detection. The majority of culture media are prepared with a final neutral pH of 7.2 ± 2. Acidophiles such as A. pasteurianus prefer a pH of less than 5.4.

In order to detect microorganisms in low pH products using ATP bioluminescence, two studies were performed at Celsis to determine the optimal enrichment medium and whether AKuScreen could be used to detect artificial and naturally contaminated product in order to release product in the shortest amount of time.

Study 1: Broth Optimization


Table II: Case Study 2, Study I, Broth Optimization
Five different fabric softeners were tested with three different broth types (Letheen, TAT and Sabouraurd Dextrose Broth). The product-broth suspensions were spiked with <10 cells of Acetobacter sp. and tested at 24, 48 and 72 hours using standard bioluminescence reagents.(See Table II)

The data indicates that Sabouraud Dextose broth (SDB) is the optimum broth for growth and detection of Acetobacter species. SDB was able to detect the product-adapted microorganism in all five fabric softener products within 72 hours using standard bioluminescence.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
75%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
0%
Raw material supply problems
25%
Regulatory restrictions
0%
Business decisions to limit production
0%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Source: Pharmaceutical Technology,
Click here